Atreca Inc Financials

Atreca Stock Summary

Atreca competes with Passage Bio, Stoke Therapeutics, Revolution Medicines, Black Diamond, and Alector. Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Atreca, Inc. was incorporated in 2010 and is based in San Carlos, California. Atreca Inc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 105 people.

Atreca Key Financial Ratios

There are many critical financial ratios that Atreca's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Atreca Inc reports annually and quarterly.

Atreca Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Atreca's current stock value. Our valuation model uses many indicators to compare Atreca value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Atreca competition to find correlations between indicators driving Atreca's intrinsic value. More Info.Atreca Inc is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Atreca's earnings, one of the primary drivers of an investment's value.

Atreca Market Pulse

Along with financial statement analysis, the daily predictive indicators of Atreca help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Atreca Inc. We use our internally-developed statistical techniques to arrive at the intrinsic value of Atreca Inc based on widely used predictive technical indicators. In general, we focus on analyzing Atreca Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Atreca's daily price indicators and compare them against related drivers.

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

If you are still planning to invest in Atreca Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Atreca's history and understand the potential risks before investing.